Alseres Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 4.9 | 5.1 | 4.5 | 5.1 | 4.1 |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | (4.9) | (5.1) | (4.5) | (5.2) | (4.2) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.0 | 0.1 | 0.1 | (0.0) | 0.1 |
| Nonoperating Expenses | 0.5 | 0.4 | 0.3 | 0.1 | -- |
| Income Before Taxes | (5.3) | (5.4) | (4.7) | (5.3) | (4.1) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (5.3) | (5.4) | (4.7) | (5.3) | (4.1) |
| Continuing Operations | (5.3) | (5.4) | (4.7) | (5.3) | (4.1) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (5.3) | (5.4) | (4.7) | (5.3) | (4.1) |
| Total Net Income | (5.3) | (5.4) | (4.7) | (5.3) | (4.1) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.26) | (0.27) | (0.22) | (0.30) | (0.25) |
| Dividends per Share | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
